Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of two traditional Chinese medicine (TCM) granule formulations. Musk Huayu Xingnao Granules and Vermiculus Huoxue Tongyu Granules are both used in TCM for the treatment of cerebrovascular and cardiovascular diseases, particularly those involving blood stasis and impaired circulation. The combination is likely intended to enhance effects such as promoting blood circulation, removing stasis, improving hemodynamics, and potentially reducing inflammation or oxidative stress. The specific ingredients in each granule are not detailed here but typically include plant-based and animal-based components common in TCM formulas for stroke or related conditions[1][5]. There is no evidence from available sources that this exact combination has been studied as a single product; rather, it appears to be a pairing of two established TCM granules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Musk Huayu Xingnao Granules + Vermiculus Huoxue Tongyu Granules.